Obalon Therapeutics, Inc.
Carlsbad, US · Founded 2008 · Delaware corporation · 1 known investors
Founders & leadership
MB
Mark BristerChief Technology Officer
KH
Kelly Huang, Ph.D.Chief Operating Officer
WJ
William J. PlovanicChief Financial Officer
AR
Andrew RasdalPresident and Chief Executive Officer
LH
Les HoweNamed on SEC filing
DF
Douglas FisherNamed on SEC filing
DM
David MoatazediNamed on SEC filing
SS
Sharon Stevenson, DVM Ph.D.Named on SEC filing
Board
KK
Kim Kamdar, Ph.D.Board director
KP
Kim Puloma KamdarBoard director
SS
Sharon StevensonBoard director
RD
Raymond DittamoreBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$27.4M disclosed across 3 rounds · 2012–2018
▶$10MraisedAug 2018 · 21 investors · BiotechnologyRule 506(b)
▶$10MraisedAug 2018 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Les HoweDirector
- Mark BristerExecutive Officer
- Kelly Huang, Ph.D.Executive Officer
- Douglas FisherDirector
- David MoatazediDirector
- Raymond DittamoreDirector
- Sharon Stevenson, DVM Ph.D.Director
- Kim Kamdar, Ph.D.Director
- William J. PlovanicExecutive Officer
- Andrew RasdalExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.9MraisedOct 2014 · 5 investors · BiotechnologyRule 506(b)
▶$15.9MraisedOct 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Doug FisherDirector
- Kim Puloma KamdarDirector
- Andrew RasdalExecutive Officer, Director
- Sharon StevensonDirector
- Offering amount
- $30M
- Amount sold
- $15.9M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMar 2012 · 2 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMar 2012 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew RasdalExecutive Officer, Director
- Douglas C. SampsonDirector
- Kim Puloma KamdarDirector
- Sharon StevensonDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2008
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Obalon Therapeutics, Inc.'s investors?
- Obalon Therapeutics, Inc.'s investors include Okapi Venture Capital.
- How much funding has Obalon Therapeutics, Inc. raised?
- Obalon Therapeutics, Inc. has disclosed $27.4M raised across 3 rounds.
- Where is Obalon Therapeutics, Inc. headquartered?
- Obalon Therapeutics, Inc. is headquartered in Carlsbad, US.